147 related articles for article (PubMed ID: 27486932)
1. VIP Family Members Prevent Outer Blood Retinal Barrier Damage in a Model of Diabetic Macular Edema.
Maugeri G; D'Amico AG; Gagliano C; Saccone S; Federico C; Cavallaro S; D'Agata V
J Cell Physiol; 2017 May; 232(5):1079-1085. PubMed ID: 27486932
[TBL] [Abstract][Full Text] [Related]
2. PACAP and VIP Inhibit HIF-1α-Mediated VEGF Expression in a Model of Diabetic Macular Edema.
Maugeri G; D'Amico AG; Saccone S; Federico C; Cavallaro S; D'Agata V
J Cell Physiol; 2017 May; 232(5):1209-1215. PubMed ID: 27661459
[TBL] [Abstract][Full Text] [Related]
3. Ameliorative effect of PACAP and VIP against increased permeability in a model of outer blood retinal barrier dysfunction.
Scuderi S; D'Amico AG; Castorina A; Imbesi R; Carnazza ML; D'Agata V
Peptides; 2013 Jan; 39():119-24. PubMed ID: 23220033
[TBL] [Abstract][Full Text] [Related]
4. Caffeine Prevents Blood Retinal Barrier Damage in a Model, In Vitro, of Diabetic Macular Edema.
Maugeri G; D'Amico AG; Rasà DM; La Cognata V; Saccone S; Federico C; Cavallaro S; D'Agata V
J Cell Biochem; 2017 Aug; 118(8):2371-2379. PubMed ID: 28106278
[TBL] [Abstract][Full Text] [Related]
5. NAP counteracts hyperglycemia/hypoxia induced retinal pigment epithelial barrier breakdown through modulation of HIFs and VEGF expression.
D'Amico AG; Maugeri G; Rasà DM; La Cognata V; Saccone S; Federico C; Cavallaro S; D'Agata V
J Cell Physiol; 2018 Feb; 233(2):1120-1128. PubMed ID: 28436035
[TBL] [Abstract][Full Text] [Related]
6. Apelin-13 Is an Early Promoter of Cytoskeleton and Tight Junction in Diabetic Macular Edema via PI-3K/Akt and MAPK/Erk Signaling Pathways.
Li Y; Bai YJ; Jiang YR; Yu WZ; Shi X; Chen L; Feng J; Sun GB
Biomed Res Int; 2018; 2018():3242574. PubMed ID: 29850504
[TBL] [Abstract][Full Text] [Related]
7. Nicotine promotes blood retinal barrier damage in a model of human diabetic macular edema.
Maugeri G; D'Amico AG; Rasà DM; La Cognata V; Saccone S; Federico C; Cavallaro S; D'Agata V
Toxicol In Vitro; 2017 Oct; 44():182-189. PubMed ID: 28689815
[TBL] [Abstract][Full Text] [Related]
8. NAP modulates hyperglycemic-inflammatory event of diabetic retina by counteracting outer blood retinal barrier damage.
D'Amico AG; Maugeri G; Rasà D; Federico C; Saccone S; Lazzara F; Fidilio A; Drago F; Bucolo C; D'Agata V
J Cell Physiol; 2019 Apr; 234(4):5230-5240. PubMed ID: 30374973
[TBL] [Abstract][Full Text] [Related]
9. PKCζ mediates breakdown of outer blood-retinal barriers in diabetic retinopathy.
Omri S; Behar-Cohen F; Rothschild PR; Gélizé E; Jonet L; Jeanny JC; Omri B; Crisanti P
PLoS One; 2013; 8(11):e81600. PubMed ID: 24312324
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of blood-retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathy.
Wisniewska-Kruk J; Klaassen I; Vogels IM; Magno AL; Lai CM; Van Noorden CJ; Schlingemann RO; Rakoczy EP
Exp Eye Res; 2014 May; 122():123-31. PubMed ID: 24703908
[TBL] [Abstract][Full Text] [Related]
11. PACAP and VIP increase the expression of myelin-related proteins in rat schwannoma cells: involvement of PAC1/VPAC2 receptor-mediated activation of PI3K/Akt signaling pathways.
Castorina A; Scuderi S; D'Amico AG; Drago F; D'Agata V
Exp Cell Res; 2014 Mar; 322(1):108-21. PubMed ID: 24246222
[TBL] [Abstract][Full Text] [Related]
12. Melatonin prevents blood-retinal barrier breakdown and mitochondrial dysfunction in high glucose and hypoxia-induced in vitro diabetic macular edema model.
Doğanlar ZB; Doğanlar O; Kurtdere K; Güçlü H; Chasan T; Turgut E
Toxicol In Vitro; 2021 Sep; 75():105191. PubMed ID: 33962019
[TBL] [Abstract][Full Text] [Related]
13. PACAP promotes neuron survival in early experimental diabetic retinopathy.
Szabadfi K; Szabo A; Kiss P; Reglodi D; Setalo G; Kovacs K; Tamas A; Toth G; Gabriel R
Neurochem Int; 2014 Jan; 64():84-91. PubMed ID: 24262293
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effects of fenofibrate in retinal pigment epithelium by the modulation of stress and survival signaling under diabetic conditions.
Miranda S; González-Rodríguez Á; García-Ramírez M; Revuelta-Cervantes J; Hernández C; Simó R; Valverde ÁM
J Cell Physiol; 2012 Jun; 227(6):2352-62. PubMed ID: 21826649
[TBL] [Abstract][Full Text] [Related]
15. Vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptides stimulate mitogen-activated protein kinase in the pituitary cell line GH4C1 by a 3',5'-cyclic adenosine monophosphate pathway.
Le Péchon-Vallée C; Magalon K; Rasolonjanahary R; Enjalbert A; Gérard C
Neuroendocrinology; 2000 Jul; 72(1):46-56. PubMed ID: 10940738
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of PACAP-38 on retinal pigmented epithelium in an in vitro and in vivo model of diabetic retinopathy through EGFR-dependent mechanism.
Maugeri G; D'Amico AG; Bucolo C; D'Agata V
Peptides; 2019 Sep; 119():170108. PubMed ID: 31247223
[TBL] [Abstract][Full Text] [Related]
17. Decorin Prevents Retinal Pigment Epithelial Barrier Breakdown Under Diabetic Conditions by Suppressing p38 MAPK Activation.
Wang S; Du S; Wu Q; Hu J; Li T
Invest Ophthalmol Vis Sci; 2015 May; 56(5):2971-9. PubMed ID: 25829413
[TBL] [Abstract][Full Text] [Related]
18. Protective factors in diabetic retinopathy: focus on blood-retinal barrier.
Zhang C; Wang H; Nie J; Wang F
Discov Med; 2014 Sep; 18(98):105-12. PubMed ID: 25227751
[TBL] [Abstract][Full Text] [Related]
19. The role of plasmalemma vesicle-associated protein in pathological breakdown of blood-brain and blood-retinal barriers: potential novel therapeutic target for cerebral edema and diabetic macular edema.
Bosma EK; van Noorden CJF; Schlingemann RO; Klaassen I
Fluids Barriers CNS; 2018 Sep; 15(1):24. PubMed ID: 30231925
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of protein kinase C delta attenuates blood-retinal barrier breakdown in diabetic retinopathy.
Kim JH; Kim JH; Jun HO; Yu YS; Kim KW
Am J Pathol; 2010 Mar; 176(3):1517-24. PubMed ID: 20110406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
